145 related articles for article (PubMed ID: 28689255)
1. Identification of morin as an agonist of imidazoline I-3 receptor for insulin secretion in diabetic rats.
Lin MH; Hsu CC; Lin J; Cheng JT; Wu MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):997-1003. PubMed ID: 28689255
[TBL] [Abstract][Full Text] [Related]
2. Investigation of morin-induced insulin secretion in cultured pancreatic cells.
Lin MH; Hsu CC; Lin J; Cheng JT; Wu MC
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1254-1262. PubMed ID: 28699234
[TBL] [Abstract][Full Text] [Related]
3. Canavanine induces insulin release via activation of imidazoline I3 receptors.
Yang TT; Niu HS; Chen LJ; Ku PM; Lin KC; Cheng JT
Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):263-8. PubMed ID: 25482045
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080.
Ball AJ; Flatt PR; McClenaghan NH
Pharmacol Res; 2000 Dec; 42(6):575-9. PubMed ID: 11058411
[TBL] [Abstract][Full Text] [Related]
5. Diosmin, a Citrus Nutrient, Activates Imidazoline Receptors to Alleviate Blood Glucose and Lipids in Type 1-Like Diabetic Rats.
Hsu CC; Lin MH; Cheng JT; Wu MC
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28665324
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
7. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
9. Activation of imidazoline receptor I
Amisten S; Duner P; Asplund O; Mohammed Al-Amily I; Groop L; Salehi A
J Diabetes Complications; 2018 Sep; 32(9):813-818. PubMed ID: 29996974
[TBL] [Abstract][Full Text] [Related]
10. The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans.
Tsoli E; Chan SL; Morgan NG
Eur J Pharmacol; 1995 Sep; 284(1-2):199-203. PubMed ID: 8549627
[TBL] [Abstract][Full Text] [Related]
11. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
12. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
Chan SL; Atlas D; James RF; Morgan NG
Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
[TBL] [Abstract][Full Text] [Related]
13. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
14. Glucose-induced insulin secretion is potentiated by a new imidazoline compound.
Mest HJ; Raap A; Schloos J; Treinies I; Paal M; Giese U; Koivisto V
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):47-52. PubMed ID: 11485038
[TBL] [Abstract][Full Text] [Related]
15. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats.
Hwang SL; Liu IM; Tzeng TF; Cheng JT
Diabetologia; 2005 Apr; 48(4):767-75. PubMed ID: 15756537
[TBL] [Abstract][Full Text] [Related]
16. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and β-cell function in streptozotocin-induced diabetic rats.
Vanitha P; Uma C; Suganya N; Bhakkiyalakshmi E; Suriyanarayanan S; Gunasekaran P; Sivasubramanian S; Ramkumar KM
Environ Toxicol Pharmacol; 2014 Jan; 37(1):326-35. PubMed ID: 24384280
[TBL] [Abstract][Full Text] [Related]
19. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets.
Chan SL; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):267-72. PubMed ID: 9696417
[TBL] [Abstract][Full Text] [Related]
20. Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans.
Cooper EJ; Hudson AL; Parker CA; Morgan NG
Eur J Pharmacol; 2003 Dec; 482(1-3):189-96. PubMed ID: 14660022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
